Skip to main content
. 2016 Aug 18;7(39):63549–63560. doi: 10.18632/oncotarget.11363

Figure 2. ALOS4 reduces cell migration and adhesion.

Figure 2

Percent control wound closure at 8 h in B16F10 cells treated for A. 24, B. 48, C. 60 and D. 72 h with ALOS4 (one-way ANOVA followed by Bonferroni means separation test; p=0.0242, *p<0.05, n=3). E. Cells were pretreated for 24 or 48 h with concentrations of ALOS4 (0.03-3 μM), then replated at a fixed cell concentration per well with an additional 24 h of ALOS4 treatment (n=4). Letters are results of a one-way ANOVA within treatment with Bonferroni means separation test (48 h: p=0.0107; 72 h: p=0.0005). Asterisks are results of a two-way ANOVA comparing pretreatment times (p=0.0072; *p<0.05).